BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 10420461)

  • 1. [Role of renin-angiotensin-aldosterone system in pathogenesis of arterial hypertension in chronic renal failure].
    Lifshits NL; Kutyrina IM
    Ter Arkh; 1999; 71(6):64-7. PubMed ID: 10420461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension.
    van den Born BJ; Koopmans RP; van Montfrans GA
    Am J Hypertens; 2007 Aug; 20(8):900-6. PubMed ID: 17679041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-angiotensin-aldosterone system in arterial hypertension.
    Horký K; Gregorová I
    Cor Vasa; 1980; 22(1-2):59-73. PubMed ID: 6995018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
    Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M
    Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activity of renin-angiotensin-aldosterone system (RAAS) and vasopressin level in patients with primary pulmonary hypertension].
    Martyniuk TV; Chazova IE; Masenko VP; Volkov VN; Belenkov IuN
    Ter Arkh; 1998; 70(4):33-6. PubMed ID: 9612899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renin-aldosterone system in patients with hypertensive form of chronic glomerulonephritis and preserved renal function].
    Borovkova NIu; Borovkov NN; Sidnev BN
    Klin Med (Mosk); 2009; 87(8):61-3. PubMed ID: 19827534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The atrial natriuretic peptide-renin-aldosterone system in hepatorenal syndrome.
    Pasqualetti P; Casale R
    Riv Eur Sci Med Farmacol; 1996; 18(4):137-41. PubMed ID: 9177611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic significance of controlled and uncontrolled arterial hypertension in patients with terminal kidney failure on chronic hemodialysis].
    Milovanova LIu; Nikolaev AIu; Lifshits NL; Milovanov IuS
    Ter Arkh; 2002; 74(6):45-9. PubMed ID: 12136483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive hormones in children with chronic renal failure.
    Rauh W; Hund E; Sohl G; Rascher W; Mehls O; Schärer K
    Kidney Int Suppl; 1983 Nov; 15():S27-33. PubMed ID: 6368949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of the renin-angiotensin-aldosterone (RAA) and secretion of the atrial natriuretic peptide (ANP) in patients with chronic renal failure.
    Irzyniec T; Kokot F; Grzeszczak W
    Mater Med Pol; 1991; 23(2):125-9. PubMed ID: 1842598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
    Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A
    Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma renin activity (PRA) and aldosterone (PA) in patients with chronic glomerulonephritis (GN) and hypertension.
    Bras H; Ochs HG; Armbruster H; Heintz R
    Clin Nephrol; 1976 Feb; 5(2):57-60. PubMed ID: 943254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The renin-angiotensin-aldosterone system in the diagnosis of renovascular arterial hypertension].
    Sánchez Torres G; Posadas C; Millán AJ; Gutiérrez Fuster E; Serrano Mass P; Rangel J; Cuéllar A
    Arch Inst Cardiol Mex; 1976; 46(2):198-212. PubMed ID: 938159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of hypertension in patients with terminal kidney failure on programmed hemodialysis].
    Krimkevich EI; Petrun' NM; Baran EIa; Kutsaĭ NN; Khomenko NV
    Ter Arkh; 1986; 58(8):81-4. PubMed ID: 3020729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulations of plasma aldosterone in young hyperkalemic patients with stable chronic renal failure.
    Radó JP; Boer P
    Endokrinologie; 1979 Apr; 73(2):173-85. PubMed ID: 467373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children].
    Peco-Antić A; Nastić-Mirić D; Babić D; Kostić M
    Srp Arh Celok Lek; 1999; 127(9-10):305-11. PubMed ID: 10649899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The mechanisms of the development of arterial hypertension in patients with chronic kidney failure treated by hemodialysis].
    Konstantinov IuV; Komandenko MS; Nikolaeva AA; D'iachuk MM
    Urol Nefrol (Mosk); 1993; (3):39-41. PubMed ID: 7941161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.